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It has been demonstrated that rabbits produce an acute phase substance analo- 
gous  to  the  human  C-reactive protein  (1).  This rabbit protein,  the  properties of 
which  are extremely similar to those of the human C-reactive protein, reacts with 
a  special  form of the  somatic C-carbohydrate of the pneumococcus,  the  so  called 
Cx-carbohydrate. The human  protein  reacts equally  well  with  either  form of  the 
carbohydrate,  whereas  the  rabbit protein  is  precipitable in  the  presence of traces 
of calcium ion only by the Cx-carbohydrate. 
Many of the properties of the Cx-reactive protein were defined at the time of its 
initial description by Anderson and McCarty (1).  Like the human  C-reactive pro- 
rein,  rabbit Cx-reactive protein  is not  normally present  in  the  blood but  appears 
in response to stimuli of the same type which  cause the appearance of the human 
protein; acute infections,  the injection of triple typhoid vaccine, and the injection 
of many foreign  substances,  among  them  antigens  such  as  the  human  C-reactive 
protein,  and  fractions of human  gamma globulin  (2).  Rabbits respond to  surgical 
injury and fracture by producing  Cx-reactive protein. 
Earlier studies  of the  C-reactive protein  and of the  Cx-reactive protein  related 
to possible  functions of these substances. In one of these  studies it was shown  that 
low concentrations of human C-reactive protein  caused increased  motility of normal 
human  leukocytes  (3).  An  extensive study  of  the  relationship  between  the  acute 
phase response and antibody production in the rabbit demonstrated  a good correla- 
tion between early appearance of Cx-reactive protein and  the subsequent production 
of precipitating antibody to  certain  antigens  (2).  During  the  course  of this  study 
it was also  found  that  the  administration  of adjuvant  alone would  cause  the  ap- 
pearance of Cx-reactive protein in large amount  (4). 
The present study stems from the observation that the  Cx-reactive protein 
when administered  intravenously to rabbits causes them to produce the  Cx- 
reactive protein in amount larger than that injected, and from the observation 
that  Cx-reactive  protein  incorporated  in  adjuvant  will,  when  administered 
intracutaneously,  cause the development of extensive local inflammatory reac- 
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tions in comparison with control animals given adjuvant containing normal 
rabbit serum albumin or adjuvant alone. 
These inflammatory reactions were consistently obtained with three differ- 
ent preparations of Cx-reactive protein incorporated in sterile adjuvant. They 
were characterized by edema about the injection site and by the development 
of marked erythema over an area at least five times the diameter of the nodule 
in the skin caused by the injection of adjuvant. Suppuration was never seen. 
Further observations employing thorotrast  suggested that  the inflammatory 
reaction which occurred in response to the injection of Cx-reactive protein in 
adjuvant might be prevented by blockade of the reticulo-endothelial system. 
Materials and Methods 
Preparation  of the Cx-Reactive Protein.--The Cx-reactive protein  employed in these ex- 
periments was obtained from pooled sera obtained from many rabbits which were bled to 
death following dermal infection with pneumococcus Type I. Three  separate preparations 
were made from three separate pools. Isolation and purification of the protein were carried 
out by the method described by Anderson and McCarty except that crystallization was not 
attempted.  The preparations  were tested  for traces of normal rabbit serum protein with a 
guinea pig antiserum to normal rabbit serum, and the concentration of protein in the solu- 
tions was determined approximately by a spectrophotometric method. 
Quantitative Determination  of the  Cx-Reactive Protein.--Sterile  solutions of  Cx-reactive 
protein in a solution 0.1 x~ in respect to both sodium chloride and sodium citrate which gave 
a capillary precipitin reaction against sheep antiserum to Cx-reactive protein of 4 ram. was 
used throughout  the  experiments. These  solutions gave  optical  density readings of 0.400 
to 0.410 at 280 mt~ in the Beckman D.U.  spectrophotometer. This corresponded approxi- 
mately to a protein concentration of 250 gamma/cc, when read on a calibration curve made 
with bovine Cohn fraction II. 
Preparation of Normal Rabbit Serum Albumin.--Pooled normal rabbit serum was fraction- 
ated with ammonium sulfate. The protein fraction which precipitated at a concentration be- 
tween 0.50 and 0.75 saturation with the salt was redissolved in a small volume of distilled 
water and dialyzed overnight against physiological saline. A solution containing 250 gamma/ 
co. was used for incorporation in adjuvant. 
Preparation of Sheep Antiserum to Cx-Reactive Protein.--High titered  precipitating  anti- 
serum to Cx-reactive protein was obtained from a sheep 4 weeks after the subcutaneous in- 
jection into six separate  skin sites of purified Cx-reactive protein incorporated into an ad- 
juvant consisting of an emulsion of two parts of antigen solution and two parts of heavy grade 
mineral oil to one part of the ointment base aquaphor. 0.5 rag. of dried, heat-killed Jamaica 
strain tubercle bacilli was incorporated in each 10 ce. of the adjuvant. 1 co. of the adjuvant 
mixture was given in each subcutaneous injection. 
Precipitin  Te~ts with the Antiserum.--The precipitin tests with antiserum to Cx-reactive 
protein were carried out in capillary tubes according to the procedure described by Anderson 
and McCarty.  This method is based on the capillary precipitin method for serologic typing 
of Group A streptococci described by Swift, Wilson, and Lancefield (5). One ram. of packed 
antigen-antibody  precipitate was read as 1 plus. All readings were made with a millimeter 
rule. In each experiment all rabbits were bled every 4 hours for the first 36 hours, and every 
12 hours thereafter. 
Preparation of Adjuvant  Containing Cx-Reactive Protein and of Adjuvant  Containing Nor- 
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adjuvant containing either Cx-reactive protein or normal rabbit serum albumin the ointment 
base aquaphor was used in preparing the adjuvant. Two parts of a solution containing 250 
gamma/ee,  of Cx-reactive protein,  or two parts of a solution containing the normal rabbit 
serum albumin, and two parts of heavy grade mineral oil were emulsified with one part of 
aquaphor. No heat-killed tubercle bacilli were added to these adjuvants. Control experiments 
other  than the ones in which normal rabbit serum albumin was used, employed adjuvants 
which were made with physiological saline. 
Tl*orotrast.--In one experiment thorotrast  (24 to 26 per cent thorium dioxide) was given 
intravenously  to three rabbits. 
Animals.--Rabbits weighing between 2500 to 3500 gin. were employed in all experiments. 
A control bleeding was done on each animal to insure the absence of Cx-reactive protein at 
the beginning of each experiment. 
TABLE I 
Capillary  Precipilin  Reaction  Readings for  Cx-Reactive Protein  Obtained at  Intervals 
Following the Intravenous  Administration  of Purified  Cx-Reactive Protein 
Rabbits 1 through 4 received 1.2 rag. of one preparation  of the protein. Rabbits $ and 6 
each received 0.64 mg.  of another preparation. 
Hrs.  Precipifin  reactions: -4- = 1 ram. precipitin 
mm.  /tim.  mm. 
0  --  --  -- 
2  ++  +  +2 
5 
24  ++++  ++++  ++++++ 
4s  i+++ [++++j  ++++  + +++  + +i +++, +l + +;  ÷ + 
RESULTS 
Findings  with  Intravenously  Administered  Cx-Reaxtive Protein.--Six rabbits were 
given Cx-reactive protein in single intravenous injections, four of them  1.2  rag.  of 
one preparation, and the other two 0.64 rag.  of a second preparation. In addition to 
taking hourly temperatures and determining hourly white blood cell counts for the 
first 8 hours following the injections, sera from the 1 hour, 5 hour, and from 24, and 
48  hour bleedings were  tested  for  Cx-reactive protein. No consistent effect  of the 
injections on temperature or white blood cell count was noted. All six of the animals, 
however, responded to the injection of  Cx-reactive protein by producing their own 
Cx-reactive protein.  Table I  shows  the precipitin reactions obtained with the sera 
from these six rabbits at intervals. The calculated amount of circulating Cx-reactive 
protein at 24 hours in each rabbit was approximately 10 mg., many fold the amount 
injected intravenously 24 hours earlier. It is worthy of note that at 5 hours none of 
the injected Cx-reactive protein was any longer detectable in the serum. 
Findings with Cx-Reactive  Protein in Adjuvant.--Cx-reactive protein incorporated 
in adjuvant was injected intracutaneously into sixteen rabbits. Four control animals 
received normal rabbit serum albumin incorporated in adjuvant intracutaneously. 
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used  in  obtaining  Cx-reactive protein.  Twelve rabbits  were  given adjuvant  alone 
as a further control.  All the animals given Cx-reactive protein in adjuvant developed 
extensive areas of erythema about the sites of injection  within  16 hours following 
the injection.  The three separate preparations of the protein were used in the experi- 
ments.  At their  height,  these  inflammatory areas ranged in  diameter from 4.5  to 
7.5  cm. The four rabbits given normal rabbit serum albumin in  adjuvant and the 
twelve animals given plain  adjuvant  did  not  develop marked inflammatory reac- 
tions about the sites  of the injections.  In Table II the diameters of the cutaneous 
lesions obtained in eight rabbits given Cx-reactive protein in adjuvant are tabulated. 
These measurements were taken when the lesions were at their height. In all instances, 
the lesions began to develop at approximately 12 hours.  They reached their maxi- 
mum size and intensity of erythema and edema at approximately 16 hours.  By 48 
hours following injection  the lesions had all decreased  considerably in size and at 72 
hours they were beginning  to disappear. 
TABLE II 
Transverse Diameters of Inflammatory Lesions in Fight Rabbits 16 Hours Following the 
Intracutoneous Injection of Cx-Reacti~e Protein in Adju~ant 
Rabbit  ..........  No  .......  1  2  3  4  5  6  7  8 
Diameters  in  I  4.5  I  4"51  4.5  4.5  5.0  4.0  5.0  5.0 
......... ix  4.5  I x  5.01  x  6.0  L x  s.olx  7.51x  5.01  x  7.01  x  7.0 
As in the instance of rabbits given Cx-reactive protein intravenously, rab- 
bits given it  in an adjuvant mixture responded  with  the  appearance of Cx- 
reactive protein  in  the  blood  within  24  hours  following injection.  Since  the 
intracutaneous injection of adjuvant without incorporated Cx-reactive protein 
can itself cause the appearance of Cx-reactive protein in the blood, the response 
of the  rabbits  cannot  be attributed  to the  Cx-reactive protein  alone  but  is 
certainly in part, at least, due to the effect of adjuvant. 
Prevention  of the  Inflammatory  Response  to  Cx-Reactive  Protein  in  Adjuvant  by 
Thorotrast.--Three  rabbits  which  had  responded  to  the  injection  of  Cx-reacfive 
protein  in  adjuvant  by the  development of  typical inflammatory reactions,  were 
injected over a period of days with 41 co. of thorotrast intravenously. 72 hours after 
the final  injection  of thorotrast they were given 1 co. of Cx-reacfive protein in ad- 
juvant intracutaneously. Marked differences in the response  of these rabbits to the 
injection of the adjuvant mixture were noted following the thorotrast. No papular 
lesion  occurred at the site of the  injection  and  after 24 hours only a  slight,  faint 
erythematous halo was evident around the nodule  which had been produced by the 
injection  of adjuvant mixture. 
DISCUSSION 
The results of the experiments described in this study indicate that the Cx- 
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either intravenously, or intracutaneously in adjuvant mixture, causes animals of 
the same species from which the acute phase protein was derived, to respond 
by producing large amounts of the same acute phase substance. This appears 
to be a  unique property of the  Cx-reactive protein. When the purified sub- 
stance is administered intracutaneously in adjuvant it causes the development 
of a  characteristic surrounding area of inflammation which is not seen when 
concentrated rabbit serum albumin incorporated in adjuvant or when adjuvant 
alone is injected. Extensive studies of the cellular response in the inflammatory 
areas have not yet been carried out. 
The findings in this study raise several questions of interest. There is as yet 
no evidence bearing on the fate of the intravenously injected Cx-reactive pro- 
tein which elicited a  Cx-reactive  protein  response  in  the  recipient  animals. 
Whether the injected protein was taken up by cells of the reticulo-endothelial 
system is not known. Further studies employing isotopically labelled Cx-reac- 
tive protein may elucidate this point. What direct role, if any,  Cx-reactive 
protein may have in the development of inflammatory reactions caused by 
agents other than artificially administered Cx-reactive protein is still unknown. 
From work done with the human C-reactive protein it is evident that condi- 
tions in addition to acute inflammation may be characterized by the presence 
of C-reactive protein. This is seen in the instance of certain malignancies and 
some blood dyscrasias (6). It follows from this observation that the C-reactive 
protein and the  Cx-reactive protein,  although present in the blood in most 
acute inflammatory disorders,  are  not solely indicators of inflammation.  It 
would appear that they represent the expression of activity of  a  widespread 
and generalized cellular system. 
SUb,MARY 
It has been found that normal rabbits respond to the intravenous adminis- 
tration of Cx-reactive protein by producing this acute phase substance. When 
Cx-reactive protein incorporated in adjuvant is injected intracutaneously, in 
addition  to  producing  Cx-reactive protein,  the  recipient  animals  develop a 
characteristic inflammatory reaction about the site of injection. This inflam- 
matory reaction can be inhibited by the prior intravenous injection of thor- 
otrast. 
BIBLIOGRAPHY 
1.  Anderson, H. C., and McCarty, Maclyn, "[he occurrence in the rabbit of an acute 
phase  protein  analogous  to  human  C-reactive  protein,  J.  Exp.  Med., 1951, 
93, 25. 
2.  Wood, Harrison F., The relationship between the acute phase response and anti- 
body production  in the rabbit. I. Correlation between the early appearance  of 
Cx-reactive protein  and subsequent  antibody production,  Y. Exp.  Med., 1953, 
98, 311. 320  STUDIES ON  THE  CX-REACTIVE PROTEIN.  I 
3.  Wood,  Harrison  F.,  Effect  of  C-reactive protein  on  normal human  leukocytes, 
Proc. Soc. Exp. Biol. and Med., 1951, 76, 843. 
4.  Wood, Harrison F., The relationship between the acute phase response and anti- 
body production  in  the  rabbit.  II. The stimulation  of Cx-reactive protein re- 
sponse by certain adjuvants  and the relation of  this  response  to  the enhance- 
ment of antibody formation, J. Exp. Med.,  1953, 98, 321. 
5.  Swift, H. F.,  Wilson, A. T.,  and  Lancefield, R. C., J. Exp. Med., 1943, 78,  127. 
6.  Roantree, Robert J.,  and Rant2,  Lowell A.,  Clinical experience with the C-reac- 
tive protein test, Arch. Int. Med.,  1955, 96, 674. 